Increased Incidence of Vertebral Fracture in Older Female Hemodialyzed Patients with Type 2 Diabetes Mellitus

被引:0
|
作者
M. Inaba
S. Okuno
Y. Kumeda
T. Yamakawa
E. Ishimura
Y. Nishizawa
机构
[1] Osaka City University Graduate School of Medicine,Department of Metabolism, Endocrinology and Molecular Medicine
[2] Shirasagi Hospital,undefined
来源
关键词
Type 2 diabetes; Fracture; Vertebra; Renal osteodystrophy; Bone mineral density;
D O I
暂无
中图分类号
学科分类号
摘要
Bone disease in hemodialysis (HD) patients with type 2 diabetes mellitus (DM) is characterized by low bone turnover (Inaba M, et al. Am J Kidney Dis 2002; 39:1261-1269), although their bone quality is yet to be determined. The present study was designed to examine whether the prevalence of vertebral fracture in female HD patients with type 2 DM, age 65 years and older, might be increased, and the relation of this fracture to bone mineral density (BMD) determined by dual X-ray absorptiometry (DXA), since few data are available on the effect of DM on bone strength at lumbar spine. The prevalence of vertebral fracture in type 2 DM HD patients was 32.3%, which was greater than that of non-DM HD patients (13.3%) when adjusted for age and HD duration. Logistic regression analysis elucidated the presence of DM and age as independent risk factors for an increased prevalence of vertebral fracture in HD patients. In non-DM HD patients, those with vertebral fracture showed age significantly higher and BMD in either lumbar spine or distal one third of radius significantly lower than the respective value in those without fracture. However, in DM HD patients, neither BMD in lumbar spine nor distal one third of radius was significantly lower in those with vertebral fracture than in those without. Furthermore, age did not differ significantly between DM HD patients with and without fracture. In conclusion, female type 2 DM HD patients, age 65 years and older, showed significantly higher incidence of vertebral fracture than non-DM HD patients. Although age and low BMD emerged as independent risk factors for vertebral fracture in non-DM HD patients, those factors failed to be a risk factor in DM HD patients, suggesting that BMD determined by DXA might not be reliable in assessing bone strength in DM HD patients.
引用
收藏
页码:256 / 260
页数:4
相关论文
共 50 条
  • [42] Type 2 diabetes mellitus and fracture risk
    Dede, Anastasia D.
    Tournis, Symeon
    Dontas, Ismene
    Trovas, George
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2014, 63 (12): : 1480 - 1490
  • [43] The incidence of type 2 diabetes mellitus in Taiwan
    Tseng, CH
    Chong, CK
    Heng, LT
    Tseng, CP
    Tai, TY
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2000, 50 : S61 - S64
  • [44] Overtreatment of older patients with type 2 diabetes mellitus in primary care
    Hart, Huberta E.
    Rutten, Guy E.
    Bontje, Kyra N.
    Vos, Rimke C.
    DIABETES OBESITY & METABOLISM, 2018, 20 (04): : 1066 - 1069
  • [45] Efficacy and safety of saxagliptin in older patients with type 2 diabetes mellitus
    Doucet, Jean
    Chacra, Antonio
    Maheux, Pierre
    Lu, Jane
    Harris, Susan
    Rosenstock, Julio
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (04) : 863 - 869
  • [46] Salivary flow and xerostomia in older patients with type 2 diabetes mellitus
    Ferreira Lima, Danilo Lopes
    Rocha Mendes Carneiro, Sandro Dias
    de Sousa Barbosa, Fladia Taciana
    de Lima Saintrain, Maria Vieira
    Herve Moizan, Jean Andre
    Doucet, Jean
    PLOS ONE, 2017, 12 (08):
  • [47] Atherogenic Index Variation in Older Patients with Type 2 Diabetes Mellitus
    Constantin, Gianina Ioana
    Pena, Catalina Monica
    Opris, Simona
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 116 : 10 - 10
  • [48] Increased prevalence of ventricular fibrillation in patients with type 2 diabetes mellitus
    Movahed, Mohammad-Reza
    Hashemzadeh, Mehrtash
    Jamal, Mazen
    HEART AND VESSELS, 2007, 22 (04) : 251 - 253
  • [49] Increased intracranial arterial resistance in patients with type 2 diabetes mellitus
    Tkác, I
    Troscák, M
    Javorsky, M
    Petrík, R
    Tomcová, M
    WIENER KLINISCHE WOCHENSCHRIFT, 2001, 113 (22) : 870 - 873
  • [50] Determinants of Increased Serum Calprotectin in Patients with Type 2 Diabetes Mellitus
    Oosterwijk, Milou M.
    Bakker, Stephan J. L.
    Nilsen, Tom
    Navis, Gerjan
    Laverman, Gozewijn D.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 11